当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants
Journal of Medicinal Chemistry ( IF 7.3 ) Pub Date : 2021-11-08 , DOI: 10.1021/acs.jmedchem.1c01574
Adam Konieczny 1 , Marcus Conrad 2 , Fabian J Ertl 1 , Jakob Gleixner 1 , Albert O Gattor 1 , Lukas Grätz 1 , Maximilian F Schmidt 3 , Eduard Neu 4 , Anselm H C Horn 2 , David Wifling 1 , Peter Gmeiner 3 , Timothy Clark 3, 4 , Heinrich Sticht 2 , Max Keller 1
Affiliation  

The family of neuropeptide Y (NPY) receptors comprises four subtypes (Y1R, Y2R, Y4R, Y5R), which are addressed by at least three endogenous peptides, i.e., NPY, peptide YY, and pancreatic polypeptide (PP), the latter showing a preference for Y4R. A series of cyclic oligopeptidic Y4R ligands were prepared by applying a novel approach, i.e., N-terminus to arginine side-chain cyclization. Most peptides acted as Y4R partial agonists, showing up to 60-fold higher Y4R affinity compared to the linear precursor peptides. Two cyclic hexapeptides (18, 24) showed higher Y4R potency (Ca2+ aequorin assay) and, with pKi values >10, also higher Y4R affinity compared to human pancreatic polypeptide (hPP). Compounds such as 18 and 24, exhibiting considerably lower molecular weight and considerably more pronounced Y4R selectivity than PP and previously described dimeric peptidic ligands with high Y4R affinity, represent promising leads for the preparation of labeled tool compounds and might support the development of drug-like Y4R ligands.

中文翻译:

线性肽神经肽 Y Y4 受体配体的 N 末端到精氨酸侧链环化导致皮摩尔结合常数

神经肽 Y (NPY) 受体家族包含四种亚型(Y 1 R、Y 2 R、Y 4 R、Y 5 R),它们由至少三种内源性肽(即 NPY、肽 YY 和胰多肽)处理(PP),后者显示出对Y 4 R 的偏好。一系列环状寡肽Y 4 R 配体通过应用一种新方法制备,即N-末端到精氨酸侧链环化。大多数肽作为 Y 4 R 部分激动剂,与线性前体肽相比,显示出高达 60 倍的 Y 4 R 亲和力。两个环状六肽 ( 18 , 24 ) 显示出更高的 Y 4R 效力(Ca 2+水母发光蛋白测定),并且在 p K i值 >10 的情况下,与人胰多肽 (hPP) 相比,Y 4 R 亲和力也更高。化合物如1824 ,与 PP 和先前描述的具有高 Y 4 R 亲和力的二聚肽配体相比,表现出相当低的分子量和明显更显着的 Y 4 R 选择性,代表了制备标记工具化合物的有希望的线索,并可能支持开发药物样Y 4 R 配体。
更新日期:2021-11-25
down
wechat
bug